Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial
Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial
Recruiting · NCT05053802 · Registry updated 2021-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial | Multiple Primary Lung Cancer | Recruiting | Phase 2 | 2021-09-23 | NCT05053802 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Pulmonary Hospital, Shanghai, China | 98 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Changhai Hospital | Shanghai | China | 31 |
| Renji Hospital | Shanghai | China | 1 |
| Ruijin Hospital | Shanghai | China | 5 |
| Shanghai First People's Hospital | Shanghai | China | 1 |
| Shanghai Pulmonary Hospital | Shanghai | China | 72 |
| Shanghai Tenth People's Hospital | Shanghai | China | 13 |